nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—Lisinopril—dilated cardiomyopathy	0.526	1	CrCtD
Nateglinide—SLC15A1—Lisinopril—dilated cardiomyopathy	0.0713	0.62	CbGbCtD
Nateglinide—Cilazapril—Lisinopril—dilated cardiomyopathy	0.056	0.178	CrCrCtD
Nateglinide—Spirapril—Lisinopril—dilated cardiomyopathy	0.056	0.178	CrCrCtD
Nateglinide—Trandolapril—Lisinopril—dilated cardiomyopathy	0.0525	0.167	CrCrCtD
Nateglinide—Ramipril—Lisinopril—dilated cardiomyopathy	0.0525	0.167	CrCrCtD
Nateglinide—Enalapril—Lisinopril—dilated cardiomyopathy	0.0525	0.167	CrCrCtD
Nateglinide—Aspartame—Lisinopril—dilated cardiomyopathy	0.0445	0.142	CrCrCtD
Nateglinide—SLC22A6—Furosemide—dilated cardiomyopathy	0.0236	0.205	CbGbCtD
Nateglinide—ALB—Furosemide—dilated cardiomyopathy	0.0201	0.175	CbGbCtD
Nateglinide—CYP2C9—cardial valve—dilated cardiomyopathy	0.00184	0.4	CbGeAlD
Nateglinide—Gastrointestinal symptom NOS—Spironolactone—dilated cardiomyopathy	0.00179	0.108	CcSEcCtD
Nateglinide—Urine output increased—Furosemide—dilated cardiomyopathy	0.000518	0.0313	CcSEcCtD
Nateglinide—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.0005	0.0302	CcSEcCtD
Nateglinide—Polyuria—Furosemide—dilated cardiomyopathy	0.000474	0.0287	CcSEcCtD
Nateglinide—Arthropathy—Lisinopril—dilated cardiomyopathy	0.000473	0.0286	CcSEcCtD
Nateglinide—Thirst—Furosemide—dilated cardiomyopathy	0.000437	0.0264	CcSEcCtD
Nateglinide—Injury—Lisinopril—dilated cardiomyopathy	0.00034	0.0205	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000324	0.0196	CcSEcCtD
Nateglinide—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00032	0.0193	CcSEcCtD
Nateglinide—SLC16A1—cardiac ventricle—dilated cardiomyopathy	0.000316	0.0686	CbGeAlD
Nateglinide—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000312	0.0189	CcSEcCtD
Nateglinide—Spirapril—ACE—dilated cardiomyopathy	0.00031	0.158	CrCbGaD
Nateglinide—Sweating—Furosemide—dilated cardiomyopathy	0.000307	0.0186	CcSEcCtD
Nateglinide—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000303	0.0183	CcSEcCtD
Nateglinide—Urticaria—Spironolactone—dilated cardiomyopathy	0.000299	0.0181	CcSEcCtD
Nateglinide—SLC16A1—myocardium—dilated cardiomyopathy	0.000297	0.0645	CbGeAlD
Nateglinide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000277	0.0167	CcSEcCtD
Nateglinide—Cilazapril—ACE—dilated cardiomyopathy	0.000276	0.14	CrCbGaD
Nateglinide—Lisinopril—ACE—dilated cardiomyopathy	0.000276	0.14	CrCbGaD
Nateglinide—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000272	0.0165	CcSEcCtD
Nateglinide—Influenza—Lisinopril—dilated cardiomyopathy	0.00027	0.0163	CcSEcCtD
Nateglinide—Ramipril—ACE—dilated cardiomyopathy	0.000267	0.136	CrCbGaD
Nateglinide—Trandolapril—ACE—dilated cardiomyopathy	0.000267	0.136	CrCbGaD
Nateglinide—Pruritus—Spironolactone—dilated cardiomyopathy	0.000266	0.0161	CcSEcCtD
Nateglinide—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000263	0.0159	CcSEcCtD
Nateglinide—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00026	0.0157	CcSEcCtD
Nateglinide—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000259	0.0157	CcSEcCtD
Nateglinide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000257	0.0156	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000251	0.0152	CcSEcCtD
Nateglinide—Malnutrition—Furosemide—dilated cardiomyopathy	0.00025	0.0152	CcSEcCtD
Nateglinide—PPARG—myocardium—dilated cardiomyopathy	0.000249	0.0541	CbGeAlD
Nateglinide—Dizziness—Spironolactone—dilated cardiomyopathy	0.000248	0.015	CcSEcCtD
Nateglinide—KCNJ11—heart—dilated cardiomyopathy	0.000248	0.0537	CbGeAlD
Nateglinide—Vomiting—Spironolactone—dilated cardiomyopathy	0.000239	0.0145	CcSEcCtD
Nateglinide—Rash—Spironolactone—dilated cardiomyopathy	0.000237	0.0143	CcSEcCtD
Nateglinide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000237	0.0143	CcSEcCtD
Nateglinide—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000236	0.0143	CcSEcCtD
Nateglinide—Jaundice—Lisinopril—dilated cardiomyopathy	0.000234	0.0142	CcSEcCtD
Nateglinide—Sweating—Lisinopril—dilated cardiomyopathy	0.000231	0.0139	CcSEcCtD
Nateglinide—ABCC8—heart—dilated cardiomyopathy	0.000228	0.0495	CbGeAlD
Nateglinide—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000227	0.0138	CcSEcCtD
Nateglinide—Nausea—Spironolactone—dilated cardiomyopathy	0.000223	0.0135	CcSEcCtD
Nateglinide—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000213	0.0129	CcSEcCtD
Nateglinide—SLC16A1—heart—dilated cardiomyopathy	0.000207	0.045	CbGeAlD
Nateglinide—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000204	0.0123	CcSEcCtD
Nateglinide—Enalapril—ACE—dilated cardiomyopathy	0.000203	0.103	CrCbGaD
Nateglinide—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000198	0.012	CcSEcCtD
Nateglinide—Amphetamine—SLC22A5—dilated cardiomyopathy	0.00019	0.0967	CrCbGaD
Nateglinide—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000188	0.0114	CcSEcCtD
Nateglinide—Back pain—Lisinopril—dilated cardiomyopathy	0.000182	0.011	CcSEcCtD
Nateglinide—SLC16A1—cardiac atrium—dilated cardiomyopathy	0.000177	0.0385	CbGeAlD
Nateglinide—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000176	0.0107	CcSEcCtD
Nateglinide—Fatigue—Furosemide—dilated cardiomyopathy	0.000176	0.0107	CcSEcCtD
Nateglinide—Tremor—Lisinopril—dilated cardiomyopathy	0.000176	0.0107	CcSEcCtD
Nateglinide—Methamphetamine—SLC22A5—dilated cardiomyopathy	0.000176	0.0896	CrCbGaD
Nateglinide—PPARG—heart—dilated cardiomyopathy	0.000174	0.0378	CbGeAlD
Nateglinide—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000167	0.0101	CcSEcCtD
Nateglinide—Palpitations—Lisinopril—dilated cardiomyopathy	0.000166	0.01	CcSEcCtD
Nateglinide—Cough—Lisinopril—dilated cardiomyopathy	0.000164	0.00992	CcSEcCtD
Nateglinide—ALB—heart—dilated cardiomyopathy	0.000163	0.0354	CbGeAlD
Nateglinide—Urticaria—Furosemide—dilated cardiomyopathy	0.000162	0.00982	CcSEcCtD
Nateglinide—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000162	0.00977	CcSEcCtD
Nateglinide—ABCC4—heart—dilated cardiomyopathy	0.000158	0.0343	CbGeAlD
Nateglinide—ABCC4—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.000152	0.00695	CbGpPWpGaD
Nateglinide—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000151	0.00911	CcSEcCtD
Nateglinide—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000148	0.00897	CcSEcCtD
Nateglinide—Asthenia—Furosemide—dilated cardiomyopathy	0.000147	0.00887	CcSEcCtD
Nateglinide—Pruritus—Furosemide—dilated cardiomyopathy	0.000145	0.00875	CcSEcCtD
Nateglinide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00014	0.00846	CcSEcCtD
Nateglinide—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.000138	0.00627	CbGpPWpGaD
Nateglinide—SLC15A2—heart—dilated cardiomyopathy	0.000136	0.0296	CbGeAlD
Nateglinide—PPARG—Noncanonical Wnt signaling pathway—RAC1—dilated cardiomyopathy	0.000135	0.00616	CbGpPWpGaD
Nateglinide—Dizziness—Furosemide—dilated cardiomyopathy	0.000135	0.00818	CcSEcCtD
Nateglinide—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000135	0.00817	CcSEcCtD
Nateglinide—PTGS1—myocardium—dilated cardiomyopathy	0.000133	0.0289	CbGeAlD
Nateglinide—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000132	0.00801	CcSEcCtD
Nateglinide—Fatigue—Lisinopril—dilated cardiomyopathy	0.000132	0.008	CcSEcCtD
Nateglinide—Vomiting—Furosemide—dilated cardiomyopathy	0.00013	0.00786	CcSEcCtD
Nateglinide—Rash—Furosemide—dilated cardiomyopathy	0.000129	0.0078	CcSEcCtD
Nateglinide—Dermatitis—Furosemide—dilated cardiomyopathy	0.000129	0.00779	CcSEcCtD
Nateglinide—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000125	0.00759	CcSEcCtD
Nateglinide—Urticaria—Lisinopril—dilated cardiomyopathy	0.000122	0.00737	CcSEcCtD
Nateglinide—Nausea—Furosemide—dilated cardiomyopathy	0.000121	0.00734	CcSEcCtD
Nateglinide—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000121	0.00733	CcSEcCtD
Nateglinide—PPARG—Wnt Signaling Pathway Netpath—GJA1—dilated cardiomyopathy	0.00012	0.00548	CbGpPWpGaD
Nateglinide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000113	0.00684	CcSEcCtD
Nateglinide—SLC16A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00011	0.00503	CbGpPWpGaD
Nateglinide—Asthenia—Lisinopril—dilated cardiomyopathy	0.00011	0.00666	CcSEcCtD
Nateglinide—Pruritus—Lisinopril—dilated cardiomyopathy	0.000109	0.00656	CcSEcCtD
Nateglinide—KCNJ11—Type II diabetes mellitus—TNF—dilated cardiomyopathy	0.000107	0.00487	CbGpPWpGaD
Nateglinide—ABCC4—Ectoderm Differentiation—DMD—dilated cardiomyopathy	0.000106	0.00485	CbGpPWpGaD
Nateglinide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000105	0.00635	CcSEcCtD
Nateglinide—SLC15A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000104	0.00474	CbGpPWpGaD
Nateglinide—CYP2C9—heart—dilated cardiomyopathy	0.000102	0.0221	CbGeAlD
Nateglinide—ABCC8—Neuronal System—ABCC9—dilated cardiomyopathy	0.000101	0.00462	CbGpPWpGaD
Nateglinide—Dizziness—Lisinopril—dilated cardiomyopathy	0.000101	0.00614	CcSEcCtD
Nateglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	0.0001	0.00456	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—ABCC9—dilated cardiomyopathy	9.84e-05	0.00448	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	9.82e-05	0.00448	CbGpPWpGaD
Nateglinide—Vomiting—Lisinopril—dilated cardiomyopathy	9.75e-05	0.0059	CcSEcCtD
Nateglinide—ABCC8—Neuronal System—ACTN2—dilated cardiomyopathy	9.73e-05	0.00443	CbGpPWpGaD
Nateglinide—Rash—Lisinopril—dilated cardiomyopathy	9.67e-05	0.00585	CcSEcCtD
Nateglinide—Dermatitis—Lisinopril—dilated cardiomyopathy	9.66e-05	0.00584	CcSEcCtD
Nateglinide—SLC15A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	9.65e-05	0.0044	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	9.63e-05	0.00439	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—ACTN2—dilated cardiomyopathy	9.43e-05	0.0043	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—ZIC3—dilated cardiomyopathy	9.43e-05	0.0043	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	9.36e-05	0.00427	CbGpPWpGaD
Nateglinide—PTGS1—heart—dilated cardiomyopathy	9.31e-05	0.0202	CbGeAlD
Nateglinide—PPARG—Wnt Signaling Pathway Netpath—RAC1—dilated cardiomyopathy	9.17e-05	0.00418	CbGpPWpGaD
Nateglinide—Nausea—Lisinopril—dilated cardiomyopathy	9.11e-05	0.00551	CcSEcCtD
Nateglinide—SLC16A1—Cell surface interactions at the vascular wall—ITGB1—dilated cardiomyopathy	9.09e-05	0.00414	CbGpPWpGaD
Nateglinide—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	8.64e-05	0.00394	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	8.52e-05	0.00388	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	8.35e-05	0.00381	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	8.12e-05	0.0037	CbGpPWpGaD
Nateglinide—PTGS1—cardiac atrium—dilated cardiomyopathy	7.96e-05	0.0173	CbGeAlD
Nateglinide—PPARG—Transcription factor regulation in adipogenesis—TNF—dilated cardiomyopathy	7.9e-05	0.0036	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—LMNA—dilated cardiomyopathy	7.69e-05	0.00351	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	7.24e-05	0.0033	CbGpPWpGaD
Nateglinide—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	7.22e-05	0.00329	CbGpPWpGaD
Nateglinide—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	7.16e-05	0.00326	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—SCN5A—dilated cardiomyopathy	7.14e-05	0.00326	CbGpPWpGaD
Nateglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—CD36—dilated cardiomyopathy	7.11e-05	0.00324	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	7.1e-05	0.00324	CbGpPWpGaD
Nateglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—dilated cardiomyopathy	6.91e-05	0.00315	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	6.9e-05	0.00314	CbGpPWpGaD
Nateglinide—ABCC4—Platelet degranulation—CD36—dilated cardiomyopathy	6.85e-05	0.00312	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TTN—dilated cardiomyopathy	6.66e-05	0.00303	CbGpPWpGaD
Nateglinide—ABCC4—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	6.53e-05	0.00298	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	6.38e-05	0.00291	CbGpPWpGaD
Nateglinide—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	6.22e-05	0.00284	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.03e-05	0.00275	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6e-05	0.00273	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.87e-05	0.00267	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.87e-05	0.00267	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—ACTN2—dilated cardiomyopathy	5.77e-05	0.00263	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.76e-05	0.00263	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.61e-05	0.00256	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.61e-05	0.00256	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	5.48e-05	0.0025	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.45e-05	0.00249	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.43e-05	0.00247	CbGpPWpGaD
Nateglinide—PPARG—PPARA activates gene expression—CD36—dilated cardiomyopathy	5.34e-05	0.00244	CbGpPWpGaD
Nateglinide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	5.29e-05	0.00241	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.28e-05	0.00241	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.28e-05	0.00241	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	5.26e-05	0.0024	CbGpPWpGaD
Nateglinide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	5.23e-05	0.00238	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.21e-05	0.00238	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	5.15e-05	0.00235	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.04e-05	0.0023	CbGpPWpGaD
Nateglinide—PPARG—Regulation of retinoblastoma protein—RAF1—dilated cardiomyopathy	5.02e-05	0.00229	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TTN—dilated cardiomyopathy	4.96e-05	0.00226	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.91e-05	0.00224	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—VCL—dilated cardiomyopathy	4.91e-05	0.00224	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.9e-05	0.00223	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.9e-05	0.00223	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	4.82e-05	0.00219	CbGpPWpGaD
Nateglinide—PPARG—PPARA activates gene expression—AGT—dilated cardiomyopathy	4.81e-05	0.00219	CbGpPWpGaD
Nateglinide—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	4.79e-05	0.00218	CbGpPWpGaD
Nateglinide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	4.71e-05	0.00215	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	4.59e-05	0.00209	CbGpPWpGaD
Nateglinide—UGT1A9—PPARA activates gene expression—CD36—dilated cardiomyopathy	4.59e-05	0.00209	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.56e-05	0.00208	CbGpPWpGaD
Nateglinide—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	4.49e-05	0.00205	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—FAS—dilated cardiomyopathy	4.49e-05	0.00205	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.47e-05	0.00204	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	4.36e-05	0.00199	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—ACTN2—dilated cardiomyopathy	4.3e-05	0.00196	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.3e-05	0.00196	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—AGT—dilated cardiomyopathy	4.21e-05	0.00192	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.2e-05	0.00191	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.18e-05	0.0019	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.18e-05	0.0019	CbGpPWpGaD
Nateglinide—UGT1A9—PPARA activates gene expression—AGT—dilated cardiomyopathy	4.13e-05	0.00188	CbGpPWpGaD
Nateglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	4.1e-05	0.00187	CbGpPWpGaD
Nateglinide—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	4.05e-05	0.00184	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—ANKRD1—dilated cardiomyopathy	3.96e-05	0.00181	CbGpPWpGaD
Nateglinide—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	3.95e-05	0.0018	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	3.89e-05	0.00177	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.89e-05	0.00177	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—ANKRD1—dilated cardiomyopathy	3.84e-05	0.00175	CbGpPWpGaD
Nateglinide—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	3.8e-05	0.00173	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—ANKRD1—dilated cardiomyopathy	3.79e-05	0.00173	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	3.78e-05	0.00172	CbGpPWpGaD
Nateglinide—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	3.76e-05	0.00172	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.74e-05	0.0017	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—TAZ—dilated cardiomyopathy	3.73e-05	0.0017	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	3.72e-05	0.0017	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	3.71e-05	0.00169	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—VCL—dilated cardiomyopathy	3.66e-05	0.00167	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.64e-05	0.00166	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.64e-05	0.00166	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—TAZ—dilated cardiomyopathy	3.61e-05	0.00165	CbGpPWpGaD
Nateglinide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	3.6e-05	0.00164	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—TAZ—dilated cardiomyopathy	3.56e-05	0.00162	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.38e-05	0.00154	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—SDHA—dilated cardiomyopathy	3.37e-05	0.00154	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	3.3e-05	0.00151	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—SDHA—dilated cardiomyopathy	3.27e-05	0.00149	CbGpPWpGaD
Nateglinide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	3.24e-05	0.00148	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—SDHA—dilated cardiomyopathy	3.22e-05	0.00147	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	3.21e-05	0.00146	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—FAS—dilated cardiomyopathy	3.17e-05	0.00145	CbGpPWpGaD
Nateglinide—PPARG—Signaling events mediated by HDAC Class I—TNF—dilated cardiomyopathy	3.13e-05	0.00143	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	3.1e-05	0.00141	CbGpPWpGaD
Nateglinide—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	3.1e-05	0.00141	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	3.09e-05	0.00141	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	3.04e-05	0.00139	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—PSEN2—dilated cardiomyopathy	3.01e-05	0.00137	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	2.95e-05	0.00135	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	2.95e-05	0.00134	CbGpPWpGaD
Nateglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—dilated cardiomyopathy	2.9e-05	0.00132	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	2.87e-05	0.00131	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	2.87e-05	0.00131	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ANKRD1—dilated cardiomyopathy	2.84e-05	0.00129	CbGpPWpGaD
Nateglinide—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	2.79e-05	0.00127	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	2.7e-05	0.00123	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—TAZ—dilated cardiomyopathy	2.67e-05	0.00122	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—NR3C2—dilated cardiomyopathy	2.53e-05	0.00115	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—ITGB1—dilated cardiomyopathy	2.46e-05	0.00112	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ANKRD1—dilated cardiomyopathy	2.44e-05	0.00111	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—SDHA—dilated cardiomyopathy	2.42e-05	0.0011	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	2.35e-05	0.00107	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—TAZ—dilated cardiomyopathy	2.3e-05	0.00105	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TTN—dilated cardiomyopathy	2.25e-05	0.00102	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—RAF1—dilated cardiomyopathy	2.21e-05	0.00101	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	2.21e-05	0.00101	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—RAF1—dilated cardiomyopathy	2.15e-05	0.000978	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—CD36—dilated cardiomyopathy	2.1e-05	0.000958	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—SDHA—dilated cardiomyopathy	2.08e-05	0.000946	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	2.05e-05	0.000936	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	1.99e-05	0.000907	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—RAC1—dilated cardiomyopathy	1.98e-05	0.000903	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	1.95e-05	0.000888	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	1.94e-05	0.000886	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	1.93e-05	0.00088	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—TNF—dilated cardiomyopathy	1.91e-05	0.000869	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	1.9e-05	0.000866	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	1.89e-05	0.000862	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	1.89e-05	0.000862	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—ITGB1—dilated cardiomyopathy	1.88e-05	0.000858	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	1.87e-05	0.000853	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—ITGB1—dilated cardiomyopathy	1.84e-05	0.000837	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	1.83e-05	0.000832	CbGpPWpGaD
Nateglinide—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	1.81e-05	0.000827	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	1.76e-05	0.000801	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	1.75e-05	0.000796	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	1.69e-05	0.000771	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VCL—dilated cardiomyopathy	1.66e-05	0.000755	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—CD36—dilated cardiomyopathy	1.61e-05	0.000732	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—NPPA—dilated cardiomyopathy	1.59e-05	0.000725	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—CD36—dilated cardiomyopathy	1.57e-05	0.000714	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—RAC1—dilated cardiomyopathy	1.51e-05	0.00069	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	1.48e-05	0.000676	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—RAC1—dilated cardiomyopathy	1.48e-05	0.000673	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	1.48e-05	0.000673	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.47e-05	0.000671	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.43e-05	0.000654	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	1.4e-05	0.000636	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	1.38e-05	0.000627	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—RAF1—dilated cardiomyopathy	1.31e-05	0.000599	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	1.3e-05	0.000591	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.29e-05	0.000589	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	1.28e-05	0.000582	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.27e-05	0.000577	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	1.26e-05	0.000575	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.23e-05	0.000562	CbGpPWpGaD
Nateglinide—ALB—Metabolism—TAZ—dilated cardiomyopathy	1.2e-05	0.000548	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.19e-05	0.000542	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	1.17e-05	0.000534	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.14e-05	0.000518	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.11e-05	0.000506	CbGpPWpGaD
Nateglinide—ALB—Metabolism—SDHA—dilated cardiomyopathy	1.09e-05	0.000495	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.07e-05	0.000488	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	1.06e-05	0.000481	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	1.05e-05	0.000477	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.03e-05	0.00047	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.01e-05	0.000458	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—RAF1—dilated cardiomyopathy	1e-05	0.000458	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.94e-06	0.000453	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	9.92e-06	0.000452	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	9.84e-06	0.000448	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—RAF1—dilated cardiomyopathy	9.79e-06	0.000446	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—GPX1—dilated cardiomyopathy	9.16e-06	0.000417	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.05e-06	0.000412	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	8.97e-06	0.000409	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—CD36—dilated cardiomyopathy	8.92e-06	0.000406	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	8.9e-06	0.000405	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—GPX1—dilated cardiomyopathy	8.88e-06	0.000405	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GPX1—dilated cardiomyopathy	8.75e-06	0.000399	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CD36—dilated cardiomyopathy	8.65e-06	0.000394	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	8.6e-06	0.000392	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CD36—dilated cardiomyopathy	8.52e-06	0.000388	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.48e-06	0.000386	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	8.31e-06	0.000379	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—AGT—dilated cardiomyopathy	8.03e-06	0.000366	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—AGT—dilated cardiomyopathy	7.79e-06	0.000355	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—AGT—dilated cardiomyopathy	7.67e-06	0.00035	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.38e-06	0.000336	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—CD36—dilated cardiomyopathy	7.09e-06	0.000323	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	6.9e-06	0.000314	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—EGFR—dilated cardiomyopathy	6.89e-06	0.000314	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—RAC1—dilated cardiomyopathy	6.68e-06	0.000305	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.63e-06	0.000302	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GPX1—dilated cardiomyopathy	6.56e-06	0.000299	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—TNF—dilated cardiomyopathy	6.56e-06	0.000299	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	6.49e-06	0.000296	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.46e-06	0.000294	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CD36—dilated cardiomyopathy	6.39e-06	0.000291	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	5.87e-06	0.000267	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.81e-06	0.000265	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AGT—dilated cardiomyopathy	5.75e-06	0.000262	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GPX1—dilated cardiomyopathy	5.64e-06	0.000257	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CD36—dilated cardiomyopathy	5.49e-06	0.00025	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.43e-06	0.000247	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.28e-06	0.000241	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AGT—dilated cardiomyopathy	4.94e-06	0.000225	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.76e-06	0.000217	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	4.74e-06	0.000216	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	4.62e-06	0.00021	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	4.6e-06	0.000209	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CD36—dilated cardiomyopathy	4.48e-06	0.000204	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—RAF1—dilated cardiomyopathy	4.43e-06	0.000202	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	4.16e-06	0.00019	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AGT—dilated cardiomyopathy	4.03e-06	0.000184	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.84e-06	0.000175	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	3.43e-06	0.000156	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	3.34e-06	0.000152	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	3.01e-06	0.000137	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GPX1—dilated cardiomyopathy	2.95e-06	0.000135	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CD36—dilated cardiomyopathy	2.88e-06	0.000131	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AGT—dilated cardiomyopathy	2.59e-06	0.000118	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	2.44e-06	0.000111	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	2.42e-06	0.00011	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	2.37e-06	0.000108	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	2.35e-06	0.000107	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.14e-06	9.74e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	2.12e-06	9.66e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.59e-06	7.26e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.55e-06	7.07e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.4e-06	6.37e-05	CbGpPWpGaD
